Recall of ORTHO BIOVUE SYSTEM ANTI A, ANTI B, ANTI AB, ANTI D, ANTI CDE

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by ORTHO CLINICAL DIAGNOSTICS.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    1999-10-28
  • Event Country
  • Event Source
    ANSM
  • Event Source URL
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    Lot ABE747A of the reagent called "ORTHO BIOVUE SYSTEM ANTI A, ANTI B, ANTI AB, ANTI D, ANTI CDE: monoclonal control" (ref 707190) of the company ORTHO CLINICAL DIAGNOSTICS is withdrawn from the market following a risk of false results positive of the negative control, preventing any validation of the results obtained with the reagent cassette.

Device

Manufacturer